EGFR and neoplasm: In contrast, samples from patients that received systemic therapy prior to tumour sampling did show higher VAF of EGFR mutations, which were detected in four patients (10%) in our cohort, and a non‐statistically significant enrichment of chromosome 6 copy number deletions.